These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24885253)

  • 1. Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes.
    Jin L; Tu J; Jia J; An W; Tan H; Cui Q; Li Z
    J Transl Med; 2014 May; 12():153. PubMed ID: 24885253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytisine - From the Past to the Future.
    Paduszyńska A; Banach M; Rysz J; Dąbrowa M; Gąsiorek P; Bielecka-Dąbrowa A
    Curr Pharm Des; 2018; 24(37):4413-4423. PubMed ID: 30885113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytisine: State of the art in pharmacological activities and pharmacokinetics.
    Wang X; Yang J; Huang P; Wang D; Zhang Z; Zhou Z; Liang L; Yao R; Yang L
    Biomed Pharmacother; 2024 Feb; 171():116210. PubMed ID: 38271893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of ΔFosB in mice.
    Sajja RK; Rahman S
    Alcohol; 2013 Jun; 47(4):299-307. PubMed ID: 23601929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytisine--a tobacco treatment hiding in plain sight.
    Rigotti NA
    N Engl J Med; 2014 Dec; 371(25):2429-30. PubMed ID: 25517710
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroprotection of Cytisine Against Cerebral Ischemia-Reperfusion Injury in Mice by Regulating NR2B-ERK/CREB Signal Pathway.
    Zhao P; Yang JM; Wang YS; Hao YJ; Li YX; Li N; Wang J; Niu Y; Sun T; Yu JQ
    Neurochem Res; 2018 Aug; 43(8):1575-1586. PubMed ID: 29948728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytisine for smoking cessation: a research agenda.
    Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytisine for smoking cessation.
    Karnieg T; Wang X
    CMAJ; 2018 May; 190(19):E596. PubMed ID: 29759967
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation.
    Castaldelli-Maia JM; Martins SS; Walker N
    Int J Drug Policy; 2018 Aug; 58():121-125. PubMed ID: 29929154
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytisine versus nicotine for smoking cessation.
    Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
    N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats.
    Grebenstein PE; Harp JL; Rowland NE
    Pharmacol Biochem Behav; 2013 Sep; 110():192-200. PubMed ID: 23876236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
    Tutka P
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1473-85. PubMed ID: 18808308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.